LCM
SOPH icon

Legato Capital Management’s SOPHiA GENETICS SOPH Stock Holding History

Legato Capital Management’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.07M Buy
+216,341
New +$1.05M 0.1% 272
2024
Q3 		– Sell
-104,083
Closed -$477K – 620
2024
Q2 		$477K Hold
104,083
– – 0.06% 451
2024
Q1 		$513K Buy
104,083
+54,184
+109% +$262K 0.06% 432
2023
Q4 		$235K Buy
+49,899
New +$187K 0.03% 514

Other funds holding SOPH

GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $6.13B AUM 15.27% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
AWA
Alta Wealth Advisors Woburn, Massachusetts $308M AUM 27.87% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Legato Capital Management's SOPH Position: Q1 2026 in Review

Legato Capital Management opened a new position in SOPHiA GENETICS (SOPH) in Q1 2026: 216,341 shares worth $1.07M. The stake represents 0.1% of the portfolio and ranks #272 among its holdings. This is a return to the name: Legato Capital Management previously reported a position in SOPH as recently as Q2 2024.

Legato Capital Management first reported a position in SOPH in Q4 2023 and has held it in 4 quarters since. 49 funds tracked by Wall St. Rank hold SOPH as of Q1 2026.

  • Legato Capital Management held 216,341 shares of SOPHiA GENETICS worth $1.07M as of Q1 2026.
  • SOPHiA GENETICS was a new Legato Capital Management position in Q1 2026.
  • SOPHiA GENETICS made up 0.1% of Legato Capital Management's portfolio in Q1 2026, its #272 holding.
  • Legato Capital Management first reported a position in SOPHiA GENETICS in Q4 2023 and has held it in 4 quarters since.
  • 49 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q1 2026.

Based on Legato Capital Management's 13F filing for Q1 2026, filed 14 May 2026.